Mansoureh Azadeh | Genetics and Bioinformatics | Excellence in Research award

Published on by Plant Scientist

Prof. Dr. Mansoureh Azadeh | Genetics and Bioinformatics | Excellence in Research award

Zist Fanavari Novin Biotechnology Institute | Iran

Dr. Mansoureh Azadeh Jouneghani is a seasoned molecular and cellular biologist, currently CEO of PreventiGene — a startup she launched in 2023 to promote cancer prevention through advanced genetic testing. With a Ph.D. in Cellular and Molecular Biology, she also founded and leads Zist Fanavari Novin Biotechnology Institute since 2011, and has taught at the university level for 20 semesters at Azad University. Over her career she has led and managed substantial research initiatives in cancer genomics, drug-resistance mechanisms in cancer (especially breast cancer), genomic biomarkers for multiple sclerosis and cardiovascular disease, athlete genomics for performance and injury prevention, and personalized medicine. She is proficient in gene expression analysis, RNA sequencing, CRISPR, bioinformatics, and high-throughput data analytics, and has supervised training in numerous molecular-biology lab techniques (PCR, qRT-PCR, ELISA, cell culture, Western blot). Her research output includes over 100 publications, covering peer-reviewed articles, conference papers, and laboratory-technique handbooks; her work has contributed significantly to genomic medicine and translational biotechnology. As a leader and educator she bridges academia, industry, and clinical research — advancing personalized medicine, improving genomic diagnostics, and fostering vocational biotech education. Her dedication continues to contribute to better health outcomes, scientific innovation, and capacity-building in biotechnology.

Profile: Google Scholar

Featured Publications

Azadeh, M., Salehzadeh, A., Ghaedi, K., & Talesh Sasani, S. (2022). NEAT1 can be a diagnostic biomarker in breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: Integrated RNA targetome… Genes and Environment.

Fattahi Dolatabadi, N., Dehghani, A., Shahand, E., Yazdanshenas, M., et al. (2020). The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer.

Adami, B., Tabatabaeian, H., Ghaedi, K., Talebi, A., Azadeh, M., & Dehdashtian, E. (2019). miR-146a is deregulated in gastric cancer. Journal of Cancer Research and Therapeutics.

Assad Samani, L., Javadirad, S. M., Parsafar, S., Tabatabaeian, H., Ghaedi, K., et al. (2019). TP53 rs1625895 is related to breast cancer incidence and early death in Iranian population. Indian Journal of Clinical Biochemistry.

Dehghan, Z., Sadeghi, S., Tabatabaeian, H., Ghaedi, K., Azadeh, M., Fazilati, M., et al. (2017). *ESR1 single nucleotide polymorphism rs1062577 (c.3804T>A) alters the susceptibility of breast cancer risk in Iranian population. Gene.

Dekui Zhang | Host-Pathogen Interactions | Best Researcher Award

Published on by Plant Scientist

Prof. Dr. Dekui Zhang | Host-Pathogen Interactions | Best Researcher Award

The Second Hospital of Lanzhou University | China

Prof. Dr. De-Kui Zhang is a distinguished gastroenterologist and Principal Investigator recognized for his extensive research in Helicobacter pylori infection, inflammatory bowel disease (IBD), gastrointestinal motility disorders, and behavioral gastroenterology. He received advanced academic training in clinical gastroenterology and molecular pathogenesis, progressing to a leading research and academic role in China. With over h-index of 19, 1345 citations, and 116 total documents, he has significantly shaped current understanding of host–pathogen interactions and chronic microbial infection. He has including four NSFC grants, advancing molecular models of microbial pathogenesis and contributing to clinical diagnostic innovations. His scholarly contributions include co-editing the academic volume Health Management of Gastritis, while his leadership roles in national academic committees—particularly within the Helicobacter pylori Group of the Chinese Society of Gastroenterology—underscore his influence on clinical guidelines and national research priorities. His work has been recognized with prestigious distinctions such as the Gansu Provincial Scientific Progress Second Prize, highlighting his impact on improving digestive health outcomes. Prof. Zhang continues to mentor emerging medical scientists and strengthen national collaborations, contributing broadly to translational gastroenterology research and patient care advancement.

Profiles: Scopus | Orcid

Featured Publications

Ma, X., Li, M., Wang, X., Xu, H., Jiang, L., Wu, F., Wei, L., Qi, G., & Zhang, D. (2024). Dihydromyricetin ameliorates experimental ulcerative colitis by inhibiting neutrophil extracellular traps formation via the HIF-1α/VEGFA signaling pathway. International Immunopharmacology.

Liu, N., Luo, Q., Gou, L., Shen, X., & Zhang, D. (2024). Knowledge and practices of Helicobacter pylori infection management among physicians in Gansu Province, China: A cross-sectional study. Helicobacter.

Gou, L., Yang, X., Yun, J., Ma, Z., Zheng, X., Du, H., & Zhang, D. (2024). Roles of the components of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori. Future Microbiology. Advance online publication.

Ma, X., Li, J., Li, M., Qi, G., Wei, L., & Zhang, D. (2024). NETs in fibrosis: Bridging innate immunity and tissue remodeling. International Immunopharmacology.

Xu, H., Huang, K., Shi, M., Gong, H., Han, M., Tian, W., Wang, X., & Zhang, D. (2024). MicroRNAs in Helicobacter pylori-infected gastric cancer: Function and clinical application. Pharmacological Research,